Decitabine 67184-0535-01

Package NDC

67184-0535-01

Manufacturer: Qilu Pharmaceutical Co., Ltd.
Dosage Form: Injection, Powder, Lyophilized, For Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: April 12, 2021
Listing Expires: December 31, 2026
Application: ANDA212826

Need to source Decitabine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Decitabine	50 mg/20mL

Drug Class

Nucleoside Metabolic Inhibitor [EPC]Nucleic Acid Synthesis Inhibitors [MoA]Nucleoside Metabolic Inhibitor [EPC]

Selected Package

67184-0535-01Selected

1 VIAL in 1 CARTON (67184-0535-1) / 20 mL in 1 VIAL